恩威医药 (301331.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

现金流量表(恩威医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
上市前/上市后 上市后上市后上市后上市后上市后上市前上市前
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 538,484,658.79367,166,769.19158,436,891.59629,757,105.05446,054,513.14303,832,856.54133,266,818.46
 收到的税费返还(元) ---1,727,206.91-510,272.47-
 收到其他与经营活动有关的现金(元) 9,500,649.559,319,359.98700,521.8910,055,411.069,798,473.391,495,463.24594,099.73
 经营活动现金流入小计(元) 547,985,308.34376,486,129.17159,137,413.48641,539,723.02455,852,986.53305,838,592.25133,860,918.19
 购买商品、接受劳务支付的现金(元) 186,868,532.96129,316,088.1557,163,085.98240,692,538.08158,888,742.44107,300,338.6353,032,536.70
 支付给职工以及为职工支付的现金(元) 147,909,484.90100,425,008.6753,920,435.27190,989,911.56143,701,389.99100,886,048.7753,915,151.80
 支付的各项税费(元) 65,284,660.6151,821,236.3027,088,623.9460,660,855.3743,851,295.6230,372,192.5814,100,069.79
 支付其他与经营活动有关的现金(元) 97,684,539.8365,129,163.9320,459,613.1386,842,214.7766,737,828.7736,797,567.7217,207,221.48
 经营活动现金流出小计(元) 497,747,218.30346,691,497.05158,631,758.32579,185,519.78413,179,256.82275,356,147.70138,254,979.77
 经营活动产生的现金流量净额(元) -29,794,632.12-62,354,203.24-30,482,444.55-
二、投资活动产生的现金流量
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) 36,000.0036,000.0013,000.00----
 收到其他与投资活动有关的现金(元) 569,334,213.60454,779,480.24224,904,095.301,050,555.02367,527.05190,519.2278,423.97
 投资活动现金流入小计(元) 569,370,213.60454,815,480.24224,917,095.301,050,555.02367,527.05190,519.2278,423.97
 购建固定资产、无形资产和其他长期资产支付的现金(元) 15,592,083.5513,879,845.875,354,862.9023,558,143.9816,568,044.0614,873,922.7211,290,796.76
 支付其他与投资活动有关的现金(元) 508,500,020.00371,500,020.00197,500,020.00221,500,000.00---
 投资活动现金流出小计(元) 524,092,103.55385,379,865.87202,854,882.90245,058,143.9816,568,044.0614,873,922.7211,290,796.76
 投资活动产生的现金流量净额(元) 45,278,110.0569,435,614.3722,062,212.40-244,007,588.96-16,200,517.01-14,683,403.50-11,212,372.79
三、筹资活动产生的现金流量
 吸收投资收到的现金(元) ---470,752,000.00470,752,000.00--
 筹资活动现金流入小计(元) ---470,752,000.00470,752,000.00--
 分配股利、利润或偿付利息支付的现金(元) 112,221,374.40112,221,374.40-----
 支付其他与筹资活动有关的现金(元) 28,036.3128,036.31-12,281,369.1812,281,369.181,403,000.00352,000.00
 筹资活动现金流出小计(元) 112,249,410.71112,249,410.71-12,281,369.1812,281,369.181,403,000.00352,000.00
 筹资活动产生的现金流量净额(元) -112,249,410.71-112,249,410.71-458,470,630.82458,470,630.82-1,403,000.00-352,000.00
四、汇率变动对现金及现金等价物的影响(元) -27,919.69-27,880.42-25,897.34163,828.65201,526.1393,259.02-7,976.51
五、现金及现金等价物净增加额(元) -16,761,130.31-13,047,044.6422,541,970.22276,981,073.75485,145,369.6514,489,300.07-15,966,410.88
 加:期初现金及现金等价物余额(元) 341,231,160.24341,231,160.24341,578,321.2464,250,086.4964,250,086.4964,250,086.4964,250,086.49
 期末现金及现金等价物余额(元) 324,470,029.93328,184,115.60364,120,291.46341,231,160.24549,395,456.1478,739,386.5648,283,675.61
补充资料:
 净利润(元) -63,962,041.92-67,801,276.37-39,187,135.04-
 资产减值准备(元) -1,235,000.36-1,649,035.72-1,821,998.09-
 固定资产和投资性房地产折旧(元) -13,156,080.45-23,140,798.57-12,577,055.71-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) -13,156,080.45-23,140,798.57-12,577,055.71-
 无形资产摊销(元) -2,876,560.69-5,369,585.60-2,872,440.38-
 长期待摊费用摊销(元) -3,288,117.87-6,879,502.37-3,457,613.21-
 处置固定资产、无形资产和其他长期资产的损失(元) -41,203.90-----
 财务费用(元) --3,710,747.60--1,561,544.67--190,519.22-
 投资损失(元) --2,059,273.88--590,476.06-85,777.65-
 递延所得税(元) -809,095.69--355,875.29-154,569.06-
  其中:递延所得税资产减少(元) --124,109.56--65,713.45--207,088.12-
 递延所得税负债增加(元) -933,205.25--290,161.84-361,657.18-
 存货的减少(元) --18,851,459.26-5,403,710.53-5,900,902.58-
 经营性应收项目的减少(元) --4,313,595.39--69,894,502.05--12,695,833.46-
 经营性应付项目的增加(元) --26,638,392.63-22,115,747.89--22,688,694.49-
 现金的期末余额(元) -328,184,115.60-341,231,160.24-78,739,386.56-
 减:现金的期初余额(元) -341,231,160.24-64,250,086.49-64,250,086.49-
 现金及现金等价物的净增加额(元) --13,047,044.64-276,981,073.75-14,489,300.07-
公告日期 2023-10-272023-08-282023-04-222023-04-222022-10-272022-09-022023-04-22
审计意见(境内) 标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院